首页> 外文期刊>Bioengineering & Translational Medicine >Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference
【24h】

Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference

机译:工程临床翻译-2017年生物工程与转化医学会议专刊简介

获取原文
           

摘要

A timely convergence of many factors, including gene-editing technologies, machine learning, nanomedicine, and artificial intelligence, is making it tremendously exciting to be an engineer at the interface ofmedicine. This is further fueled by the recognition that we need boldstrategies to tackle health care challenges across the world includingways to prevent autism and Alzheimer’s, making medicines economical,and speeding up the process of translation. Bringing perspectives fromacross the spectrum of stakeholders is critical to speeding up translation.Engineers are well positioned be an enabling community in this regard.Recognizing this opportunity, the American Institute of Chemical Engineers (AIChE) and Society of Biological Engineers (SBE) launched thisjournal and the conference series starting in 2016. The second conference in this series was held in Minneapolis on the heels of the annualAIChE meeting from October 28–29 (Co-chairs: Ali Khademhosseiniand Efie Kokkoli), featuring exciting talks and posters covering focusareas such as stem cells/regenerative medicine, immunoengineering,regulatory aspects, biopharmaceuticals and gene/drug delivery. Theseare being highlighted in this issue edited by Rangaramanujam Kannan(Johns Hopkins Medicine) and Samir Mitragotri (Harvard).
机译:包括基因编辑技术,机器学习,纳米医学和人工智能在内的许多因素的及时融合,使成为一名医学界的界面工程师变得异常兴奋。认识到我们需要更大胆的战略来应对全球医疗保健挑战,这进一步加剧了这一挑战,包括预防自闭症和阿尔茨海默氏症的方法,使药物经济并且加快翻译过程。为加快翻译速度,至关重要的是要从各个利益相关者的角度出发提出意见。工程师在这方面处于有利地位,是一个有能力的社区。美国化学工程师学会(AIChE)和生物工程师学会(SBE)认识到这一机会,于是发表了本月刊,会议系列于2016年开始。该系列的第二次会议是在10月28日至29日举行的AIChE年度会议之后(在联席主席:Ali Khademhosseini和Efie Kokkoli的主持下)在明尼阿波利斯举行的,主题是激动人心的演讲和海报,涵盖了诸如茎等重点领域细胞/再生医学,免疫工程,调节方面,生物制药和基因/药物输送。这些在本期由Rangaramanujam Kannan(约翰霍普金斯大学医学院)和Samir Mitragotri(哈佛大学)编辑的书中得到了强调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号